Seqens Seqens

X

Find the latest Drugs in Development and Pipeline Prospector News of EyeCRO.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
EyeCRO
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
5301 N. Beverly Drive Oklahoma City,OK73105
Telephone
Telephone
(405)604-8954
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

The licensing agreement with EyeCRO grants InMed an exclusive, worldwide license to develop and commercialize prospective therapeutic formulations combining MiDROPS® with any and all cannabinoid molecules.


Lead Product(s): Cannabinol

Therapeutic Area: Ophthalmology Product Name: INM-088

Highest Development Status: PreclinicalProduct Type: Small molecule

Partner/Sponsor/Collaborator: InMed Pharmaceuticals

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Licensing Agreement December 03, 2020

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY